Cardiology in Review
Scope & Guideline
Innovating the future of heart health through rigorous analysis.
Introduction
Aims and Scopes
- Clinical Innovations and Treatments:
The journal emphasizes novel treatment approaches and technologies in cardiology, including both pharmacological and non-pharmacological interventions. This includes a focus on innovative surgical techniques, device therapies, and the application of new medications. - Epidemiology and Risk Factors:
'Cardiology in Review' addresses the epidemiological aspects of cardiovascular diseases, exploring risk factors, trends, and their implications for public health. This encompasses studies on the prevalence of diseases, their associations with other health conditions, and demographic impacts. - Pathophysiology and Mechanisms of Disease:
A significant focus is on understanding the underlying mechanisms of cardiovascular diseases, including genetic, molecular, and physiological factors. This contributes to better diagnostic and therapeutic strategies. - Systematic Reviews and Meta-Analyses:
The journal frequently publishes systematic reviews and meta-analyses, which synthesize existing research findings. This approach provides a comprehensive overview of current knowledge and highlights gaps in the literature. - Interdisciplinary Perspectives:
The journal incorporates interdisciplinary approaches, recognizing the interconnectedness of cardiovascular health with other medical fields such as nephrology, endocrinology, and infectious diseases. This broadens the scope of cardiovascular research.
Trending and Emerging
- Impact of COVID-19 on Cardiovascular Health:
A significant increase in studies addressing the cardiovascular implications of COVID-19, including its effects on patients with pre-existing conditions and the management of cardiac complications post-infection. - Integration of Technology in Cardiology:
Emerging themes focus on the use of technology, including telemedicine, mobile health applications, and remote monitoring devices, which have gained traction in the management of cardiovascular diseases. - Personalized and Precision Medicine:
There is a growing emphasis on personalized treatment approaches, with studies exploring genetic and molecular profiling to tailor cardiovascular therapies to individual patients. - Long-term Outcomes and Quality of Life in Cardiac Patients:
Recent publications are increasingly focusing on long-term outcomes and the quality of life of patients with cardiovascular diseases, highlighting the importance of holistic care beyond immediate clinical interventions. - Chronic Disease Management and Multimorbidity:
Research is trending towards understanding the management of cardiovascular diseases in the context of multimorbidity, exploring how cardiovascular health intersects with other chronic conditions.
Declining or Waning
- Traditional Risk Factor Models:
Research focusing solely on traditional cardiovascular risk factors (e.g., cholesterol, hypertension) appears to be waning as newer studies emphasize more complex interactions and novel biomarkers. - Static Surgical Techniques:
Papers centered around established surgical techniques without innovation are becoming less common, as the field shifts towards minimally invasive and technologically advanced procedures. - Basic Pharmacological Studies:
There is a noticeable decline in the publication of studies examining basic pharmacological properties of medications, with a greater emphasis on clinical outcomes and real-world effectiveness of treatments. - Aging Population Studies:
While still relevant, the focus on aging populations and their unique cardiovascular challenges has decreased, possibly due to the increasing interest in acute and emergent cardiovascular conditions. - Generalized Guidelines for Cardiovascular Disease Management:
The journal has seen a reduction in articles that merely reiterate existing guidelines without providing new insights or evidence, as the emphasis shifts toward personalized medicine and individualized treatment strategies.
Similar Journals
Heart International
Elevating the discourse on heart health with impactful research.Heart International is a prominent open-access journal dedicated to the fields of cardiology and cardiovascular medicine, published by TOUCH MEDICAL MEDIA LTD since 2006. Based in Italy, this journal serves as a vital platform for researchers, clinicians, and students, aiming to disseminate cutting-edge scientific findings and clinical insights that advance the understanding of heart health. With an ISSN of 2036-2579 and an emphasis on accessible content, Heart International ensures that valuable research is available to a wide audience, thereby contributing to the global discourse on cardiovascular issues. Although it currently holds a Q4 quartile ranking in its category and is positioned in the lower percentile for Scopus rankings, the journal is committed to improving its impact through rigorous peer review and high-quality publications. The journal covers a wide array of topics within the cardiology domain, making it an essential resource for those looking to stay abreast of the latest developments in heart research.
Cardiology Journal
Elevating standards in heart health scholarship.Cardiology Journal, published by VIA MEDICA, stands as a prominent resource in the field of cardiology and cardiovascular medicine, with an ISSN of 1897-5593 and an E-ISSN of 1898-018X. Recognized for its Open Access model established since 1994, this journal facilitates widespread dissemination of critical research findings, allowing practitioners and researchers globally to access valuable insights without barriers. Based in Poland, with an address at UL SWIETOKRZYSKA 73, 80-180 GDANSK, it has achieved a respectable Q2 classification in 2023 for both Cardiology and Miscellaneous Medicine categories, reflecting its influence and quality within the scholarly community. With a Scopus ranking placing it at #117 out of 387 in Cardiology, it lies within the 69th percentile, underpinning its commitment to advancing knowledge in cardiovascular health. The journal’s converged years extending from 2006 to 2024 ensure it captures ongoing developments in a rapidly evolving field. As such, the Cardiology Journal serves as an indispensable platform for researchers, professionals, and students dedicated to exploring the frontiers of cardiac science and improving patient care.
Cardiology Research
Pioneering innovative research in cardiology and heart health.Cardiology Research is a prominent open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine, published by ELMER PRESS INC. Renowned for its rigorous peer-review process, the journal provides a platform for cutting-edge research and innovative clinical practices in cardiology. With an ISSN of 1923-2829 and an E-ISSN of 1923-2837, it has established an impactful presence in the academic community, achieving a 2023 Scopus quartile ranking of Q3 in its category, positioning it in the 41st percentile. The journal's scope encompasses various aspects of cardiology research, including but not limited to epidemiology, diagnostics, therapeutics, and cardiovascular interventions. Although it operates without open access in certain contexts, it provides flexible access options for readers, ensuring that its valuable insights are widely disseminated. Cardiology Research is an essential resource for researchers, healthcare professionals, and students who aspire to stay at the forefront of cardiovascular science, contributing significantly to the global discourse on heart health.
Revista de la Federacion Argentina de Cardiologia
Driving progress in cardiovascular research and practice.Revista de la Federacion Argentina de Cardiologia is a vital publication in the field of Cardiology and Cardiovascular Medicine, providing a platform for researchers and healthcare professionals to share significant findings and innovative concepts since its inception in 2012. Published by the Federacion Argentina Cardiology, this journal specifically addresses contemporary issues and advancements within cardiology, contributing to the scholarly dialogue essential for improving cardiovascular health. Despite being categorized in the Q4 quartile for 2023 and presently ranking #358 out of 387 in its field, the journal remains committed to fostering academic inquiry and disseminating valuable research for both local and global audiences. Although it is not an open-access journal, it strives to balance accessibility with rigorous academic standards, ensuring quality contributions that are critical for practitioners and students alike. The journal’s ongoing evaluation and adaptation in the ever-evolving landscape of cardiology underscore its importance in advancing cardiovascular science and practice.
Journal of the Practice of Cardiovascular Sciences
Shaping the Future of Cardiovascular Health Through Open AccessJournal of the Practice of Cardiovascular Sciences, published by Wolters Kluwer Medknow Publications, is an esteemed Open Access journal dedicated to advancing knowledge in the field of cardiovascular health. With its ISSN 2395-5414 and E-ISSN 2454-2830, the journal serves as a vital platform for researchers, healthcare professionals, and students to disseminate and access high-quality studies, innovations, and practical applications related to cardiovascular sciences. Established in 2015 as an Open Access journal, it promotes widespread sharing of insights to enhance cardiovascular practices and address contemporary challenges in the field. As part of a reputable publishing group, the journal is poised for growth and impact, contributing significantly to the ongoing dialogue in cardiovascular research and clinical practice.
Clinica e Investigacion en Arteriosclerosis
Advancing cardiovascular knowledge for a healthier tomorrow.Clinica e Investigacion en Arteriosclerosis is a premier academic journal dedicated to the field of cardiology and cardiovascular medicine, published by ELSEVIER. With its ISSN 0214-9168 and E-ISSN 1578-1879, the journal aims to disseminate high-quality research and innovations in the understanding and treatment of arterial diseases, contributing significantly to both clinical practices and pharmacological advancements. Established in 2007 and continuing into 2024, the journal has garnered recognition with a notable Q3 categorization in both Cardiology and Cardiovascular Medicine and Pharmacology (medical) for 2023, reflecting its impact in the academic community. Researchers and healthcare professionals utilizing this journal will find a diverse range of articles exploring novel therapeutic strategies and epidemiological data, making it an essential resource for advancing knowledge and practice in cardiovascular health. While it does not operate as an open-access journal, the findings published in Clinica e Investigacion en Arteriosclerosis are pivotal for understanding current trends and future directions in cardiovascular research.
Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
Advancing cardiovascular knowledge for a healthier tomorrow.Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology is a prominent peer-reviewed journal dedicated to advancing the field of cardiology and cardiovascular medicine. Published by KARE PUBL, this journal has established itself as a key resource for researchers, healthcare professionals, and students since its inception in 1990. As an Open Access journal since 2017, it ensures that cutting-edge research and clinical findings are readily accessible to a global audience, thus fostering collaboration and knowledge sharing among the cardiology community. With its recent rank in the Q3 quartile for Cardiology and Cardiovascular Medicine in 2023, and a Scopus rank of #282 out of 387, the journal is positioned to enhance its influence in the cardiovascular field, offering valuable insights and promoting evidence-based practices. The journal covers a wide range of topics within cardiology and cardiovascular research, making it an essential platform for scholars aiming to contribute to the ongoing dialogue in this vital area of medicine. For those eager to stay updated with the latest research trends and clinical practices in cardiology, Turk Kardiyoloji Dernegi Arsivi represents a crucial resource.
Journal of Cardiovascular Medicine
Uncovering Breakthroughs in CardiologyWelcome to the Journal of Cardiovascular Medicine, a leading platform for the dissemination of high-quality research in the field of cardiology and cardiovascular medicine. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an ISSN of 1558-2027 and an E-ISSN of 1558-2035, reflecting its commitment to accessible and innovative cardiovascular research. With a significant impact factor and ranked Q2 in both Cardiology and Cardiovascular Medicine as well as in Medicine (Miscellaneous) for 2023, the journal is recognized for its contributions to advancing knowledge and practice in this critical area of health. The journal disseminates original research, reviews, and clinical studies, aimed at clinicians, researchers, and healthcare professionals who are dedicated to improving cardiovascular health outcomes. With a continuous commitment to evolving research from 2006 to 2024, the journal is an essential resource for those looking to stay at the forefront of the latest discoveries and methodologies in cardiovascular medicine.
Journal of Atherosclerosis and Thrombosis
Leading the charge in cardiovascular research excellence.Journal of Atherosclerosis and Thrombosis is a leading academic publication dedicated to advancing research in the fields of cardiovascular medicine, biochemistry, and internal medicine. Published by the Japan Atherosclerosis Society, this esteemed journal operates from its headquarters in Tokyo, Japan, and has been a vital resource in its area since its inception in 1994. With its robust impact in Cardiology and Cardiovascular Medicine, ranking in the top quartile (Q1) as of 2023, and a commendable standing in Internal Medicine and Biochemistry, the journal fosters an environment of innovation and discovery, showcasing significant studies and advancements that shape clinical practices and therapeutic approaches. Though not an open-access publication, it offers a wealth of insights to researchers, professionals, and students seeking to deepen their understanding of atherosclerosis and thrombosis. By continually featuring high-quality articles, the Journal of Atherosclerosis and Thrombosis plays an essential role in bridging the gap between research and practice, facilitating critical conversations that influence the future of cardiovascular health.
Giornale Italiano di Cardiologia
Fostering Dialogue for a Healthier HeartGiornale Italiano di Cardiologia is a premier journal in the field of cardiology, published by PENSIERO SCIENTIFICO EDITORE. Established in 1996, this journal serves as an essential platform for sharing the latest research and clinical advancements in cardiovascular medicine, particularly catering to the Italian and international medical communities. Although currently classified in the Q4 quartile for Cardiology and Cardiovascular Medicine (2023), the journal strives to enhance its impact and outreach by embracing rigorous peer-review practices and promoting high-quality submissions. With a commitment to enriching knowledge and fostering dialogue among researchers, clinicians, and students, the journal offers a collection of articles that include original research, reviews, and case studies. While currently not an Open Access publication, readers will benefit from a wealth of research insights that contribute to advancements in cardiac care and treatment strategies. As the Giornale Italiano di Cardiologia continues to evolve, it plays a vital role in bridging research and clinical practice in the cardiovascular domain.